The Middle East stock markets have recently shown mixed performances, influenced by fluctuating oil prices and anticipation of potential U.S. Federal Reserve rate cuts, which could impact regional monetary policies due to currency pegs. In this environment, identifying stocks with strong fundamentals and growth potential becomes crucial, as these factors can help navigate the uncertainties of the current economic landscape.

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

Al Wathba National Insurance Company PJSC

10.97%

10.37%

3.14%

★★★★★★

Baazeem Trading

8.48%

-1.74%

-2.37%

★★★★★★

Sure Global Tech

NA

11.95%

18.65%

★★★★★★

Saudi Azm for Communication and Information Technology

1.94%

16.33%

21.26%

★★★★★★

MOBI Industry

6.50%

5.60%

24.00%

★★★★★★

Najran Cement

14.76%

-3.67%

-26.79%

★★★★★★

Nofoth Food Products

NA

15.75%

27.63%

★★★★★★

Qassim Cement

0.30%

0.78%

-14.65%

★★★★★☆

National General Insurance (P.J.S.C.)

NA

14.58%

25.09%

★★★★★☆

Etihad Atheeb Telecommunication

0.97%

37.69%

60.25%

★★★★★☆

Click here to see the full list of 200 stocks from our Middle Eastern Undiscovered Gems With Strong Fundamentals screener.

Here we highlight a subset of our preferred stocks from the screener.

Simply Wall St Value Rating: ★★★★★☆

Overview: Gulf Pharmaceutical Industries P.S.C., known as Julphar, operates in the manufacturing and sale of pharmaceutical, cosmetic, and medical products across the UAE, other GCC countries, and internationally with a market capitalization of AED1.57 billion.

Operations: Julphar’s revenue primarily stems from its manufacturing segment, which generated AED640.80 million. The company has a segment adjustment of AED1.03 billion that impacts its financials.

JULPHAR, a pharmaceutical player in the Middle East, has seen its debt to equity ratio improve significantly from 128.5% to 39.9% over five years, suggesting better financial management. Despite a volatile share price recently, the company achieved profitability this year with net income of AED 157.9 million for the first half of 2025 compared to a loss last year. Sales rose to AED 707.3 million from AED 675.8 million previously, reflecting steady revenue growth. However, interest payments are not well covered by EBIT at just 2.1x coverage, indicating potential challenges in managing debt obligations effectively.



Source link

Shares:
Leave a Reply

Your email address will not be published. Required fields are marked *